Global Harmonization: Latin America Overview and Perspective

Similar documents
Update on ANVISA Bioanalytical Method Validation (BMV) Guideline

AAPS Views on Bioanalytical Method Validation Harmonization (on Behalf of AAPS Bioanalytical Community)

Current Developments in Guidance for Regulatory Bioanalysis

Senior Management Team Meeting Target setting in Latin America

GLOBAL BIOANALYSIS CONSORTIUM

The regulatory landscape Stephen White on behalf of the EBF

La#n America: Regulatory trends across the region

Updates on the Progress of the. Harmonization Teams (GBC-HT) for Small & Large Molecules

Regulated bioanalysis status in Japan and notable points of the draft Japanese guideline

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Academic Research in LA

Bioanalytical Issues when. Brigitte Pellerin Bioanalytical Associate Director

AAPS/PSCW 2010 APQ Open Forum

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

GLOBAL BIOANALYSIS CONSORTIUM

Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

4/10/2017. Placement of Biomarker Analysis in a CLIA or Bioanalytical Laboratory

Current Status in Latin America

GLOBAL BIOANALYSIS CONSORTIUM

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

Report and Action Plan

Disclaimer. The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be

Probiotics in Latin America. Regulation, Market and Trends

Influenza Vaccine Use In the Americas

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D. Akwatu Kenthi, MA Centre for Addictions and Mental Health CAMH

Overview of the ProVac Initiative

Geographical Symposium: ACP countries, South Africa, Latin America. Consultation on EU Agri-Food Export Interests Brussels, 25 June 2007

Regional Update EW 31, 2014 Influenza and other respiratory viruses (August 12, 2014)

1 st LATIN AMERICA COUNTRIES MEETING - BRIEF REPORT INSTITUTO LATINOAMERICANO DE SEPSIS - ILAS SÃO PAULO MAY 30 th 2018

_flu.asp. States. North. The Caribbean and (Cuba, South. South. B was observed.

BRAZIL : what s new in the Regulations for Nutrition? Ary Bucione Danisco / DuPont

Regional Update EW 30 Influenza (August 9, h GMT; 12 h EST)

JBF Annual Report FY2014

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

Challenges in Performing a Scientifically Meaningful Lipemic Plasma Test in Bioanalytical Method Validation

Regional Update Pandemic (H1N1) 2009 (May 24, h GMT; 12 h EST)

The 6 th JBF Symposium Program Challenge of Regulated Bioanalysis

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

Rubella and CRS Elimination in the Americas

The reality of cancer clinical trials in Latin America

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Deborah Chen MPH The Heart Foundation of Jamaica

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward

Overview of the PAHO strategy and activities to strengthen National Regulatory Authorities in the Americas

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

***** Integrated Vector Management/IVM: a regional perspective

Regional Update Influenza (August 16, h GMT; 12 h EST)

INAHTA Workshop: How to Set up an HTA Agency

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY

CICAD INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

Biomarker classification: a philosophical introduction.

GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT MEMBER STATES

The 6 th JBF Symposium Program (draft) Challenge of Regulated Bioanalysis

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

Bioequivalence Requirements: USA and EU

Safety of the Blood Supply in Latin America

Building Zika preparedness in the Region of the Americas: research response

FORO: Enhancing Radiation Protection and Nuclear Safety in Ibero-America

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Implementation of the Minamata Convention on Mercury in the Interim Period until Entry into Force

ICH M4E(R2): Revised Guideline on Common Technical Document -- Efficacy

R. Sankaranarayanan MD

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

Brazil: The Gem of Latin America. October 2011

Taking vaccine effectiveness into public health decision making: The ProVac Example

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

Spanish Info Service for Rare Disease

_flu.asp. region States. North. The Caribbean and. South. region. South

World Drug Report 2008: Paraguay

GLOBAL OUTLOOK ECONOMIC WATCH. March 2018

CERTIFIED PADOVAN THERAPIST TRAINING PROGRAM

Special Topic. The ten leading causes of death in countries of the Americas

Data, open data and big data: challenges and opportunities

Economics of Tobacco in Argentina

ILC- ARGENTINA ANNUAL REPORT ( )

Translating Science to end HIV in Latin America and the Caribbean

WORLD RADIOLOGY DAY 2013

Therapeutic Apheresis in South America

MEETING REPORT: PREVENTION STRATEGIES FOR CHRONIC KIDNEY DISEASE IN LATIN AMERICA

Building a strategy for 2025: uniting evidence and policy to achieve cancer control for all

Genetic Disorders and Congenital Defects in Latin America and the Caribbean

FERTILITY DECLINE AND PUBLIC POLICIES TO ADDRESS POPULATION RIGHTS: PERSPECTIVE FROM LATIN AMERICA

***** The Entomology in Public Health and Vector Control in the Americas: Advances and Challenges

XXVI CINP CONGRESS. mood disorders: The application. Gerhard Heinze M.D.

World Health Day 2013 Remarks of PAHO Director Carissa F. Etienne

Assay Cross Validation

Regional Update EW 41 Influenza (October 25, h GMT; 12 h EST)

Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

Healthy Caribbean 2012 Rallying for Action on NCDs

countries do not have information available for this indicator.

Transcription:

Av. Andrade Neves, 295 - Sala 184 - Ed. Torre São Paulo - Centro - Campinas/SP CEP: 13013-160 - F:(+55-19)3231 8146 secretaria@acbio.org.br - www.acbio.org.br Global Harmonization: Latin America Overview and Perspective Rafael E. Barrientos Astigarraga, PhD, BChem MAGABI Pesq. Clín. Farm. Ltda. for ACBio-Br EBF - European Bioanalysis Forum - 3rd Open Symposium Date: 1-3 December 2010 1

Introducing ACBio-Br Founded in 2006 Legally since February, 2007 Website www.acbio.org.br Nowadays ACBio has 12 members Board: Dr. Eduardo Abib (Scentryphar) President Dr. Rafael Barrientos (Magabi) Vice President BSc. Fabiana Fernandes (ICF) Secretary BSc. Eunice Suenaga (NuBEC) Treasurer ACBio is the former member of the Latin America Bioavailability and Bioequivlence Network (RLABB) HT for LATAM called as GBC LATAM 2

Members (12) Introducing ACBio-Br BIOAGRI (Piracicaba/SP) BIOCINESE (Toledo/PR) CAEP (Campinas/SP) CEBIFAR (Santa Maria/RS) CEBIO (Belo Horizonte/MG) CORE (Bragança/SP) ICF (Goiânia/GO) Instituto Claudia Marques (Pouso Alegre/MG) MAGABI (São Paulo/SP) NUBEC (São Paulo/SP) SCENTRYPHAR (Campinas/SP) T&E Analítica (Campinas/SP) UNIFAG (Bragança/SP) 3

Introducing ACBio-Br Technical forum for the discussion of the analytical part of the BE studies (bioanalysis) Participants: all members of ACBio and other invited CROs Philosophy of the discussions Driven by scientific basis Technical rational behind each point to be discussed Universality of the decisions each member should be able to follow the harmonized rule 4

Introducing ACBio-Br Main achievements Technical discussions using workshops in order to have information exchange I Workshop (Feb. 2 nd, 2008) II Workshop (July 22 th, 2008) III Workshop (June 8 th, 2010) more than 150 attendees IV Workshop (Nov. 16 th, 2010) capped to 150 attendees Specific discussions together with Coordination of Bioequivalence - ANVISA in order to clarify some points of the Brazilian guidelines Questions are being treated in block rather than individually by each BA lab To harmonize the understanding of the bioanalytical guidelines among the members of ACBio To become member of the SC of GBC 5

Av. Andrade Neves, 295 - Sala 184 - Ed. Torre São Paulo - Centro - Campinas/SP CEP: 13013-160 - F:(+55-19)3231 8146 secretaria@acbio.org.br - www.acbio.org.br Brief overview on the present situation of bioanalysis (BA) in LATAM countries 6

Where are we? 7

Overview in LATAM Countries with implemented BA guidelines México Chile Uruguay Brazil Argentina Countries with under discussion how to implement guidelines Peru Colombia Countries with no guidelines Ecuador Bolivia Paraguay Venezuela Costa Rica Most of the countries in Central America and Caribbean 8

BA Guidelines in LATAM The implemented BA guidelines are more related to BE studies Most of them are based on ICH, FDA and/or EMEA ones PAHO (PanAmerican Health Organization) support projects for harmonization of requirements in LATAM countries The guidelines highlight the requirements for following the GLP QA unit Documentation (traceability) Report 9

BA Guidelines in LATAM In a general perspective, the requirements for Bioanalytical Method Validation in Latin America are aligned to the FDA and EMEA guidelines Selectivity/specificity Linearity Accuracy and precision Recovery Stability in biological matrix Freeze-and-thaw Short-term Long-term Post-processing (autosampler) Stock solution stability Use of a validated bioanalytical into the routine Run acceptance criteria Use of QCs samples 10

Regulatory agency: Brazil ANVISA (National Health Surveillance Agency) Coordination of Bioequivalence (COBIO) Bioanalytical laboratories are certified by COBIO/ANVISA (called Bioequivalence Centres) Annually inspected BA/BE Studies conducted into a not certified CROs are not accepted by ANVISA The list of BE centers are into the web site www.anvisa.gov.br Guidelines regarding bioanalysis RE899/03 Guideline for Analytical and Bioanalytical Method Validation Official Documents: Clarifications on RE899 RE 1170/06 Guideline for BE Studies (include bioanalysis) RE 895/03 Guideline for reporting data RDC 103/03 Inspection check-list and certification for Good BE Practices 11

Brazil Focus of the Guidance are related to BD/BE Studies PK studies, TDM or LBA are incipient yet LBA are expected to be included into the next revision of the guideline on BMV The 1 st guideline has been published in 1999 The bioanalytical guideline have been reviewed 3 times The actual guideline (RE899) is under revision since the Q3 of this year and a draft is expected to be published by the Q1/Q2 of 2011 30 Bioequivalence Centers certified by ANVISA +400 BE studies conducted in Brazil last year (2009) ACBio members are responsible for 70-75% of the total amount of BD/BE studies All the BE centers which conduct BA are equipped with LC-MS/MS systems 12

México Regulatory agency: COFEPRIS (Federal Commission for the Protection against Sanitary Risk) Bioanalytical labs (called Terceros Autorizados) are inspected every 2 years by COFEPRIS The list is available at the website www.cofepris.gob.mex Guidelines regarding BA NOM-177-SSA1-1998 It is not up to date and no harmonized to FDA/EMEA guidances It is under revision but it is not expected to cover the specificity of the LC-MS/MS technique 13

México There are not BA forums or either a representative organization in this country Guidelines are also focused on BE studies 100% of the BE study should be conducted in México It is likely a restraint of trade LC-MS/MS technique is still growing 3-4 BA labs are equipped with LC-MS/MS systems 14

Regulatory agency: Argentina ANMAT (National Administration of Food, Medicines and Medicinal Technology) www.anmat.gov.ar There is no a certification program for BA labs ANMAT use to make inspection BA labs are mostly focused on academic issues There is not a list of BA labs available Guidelines ANMAT Resolution 6677/10 BPC for Clinical Assays including BE studies Resolution 4844/10 Guidaline for the analytical part of Bioavailability and Bioequivalence studies Fews labs using LC-MS/MS systems 3-4 at all 15

Chile Regulatory agency: Chile and Uruguay ISP (Public Health Institute) Resol. 727/05 Technical guide G-BIOF 01/2007 Guideline harmonized with FDA ISP certifies BA labs Just 1 lab certified IFT Medicine Shcool University of Chile Uruguay Regulatory agency M.S.P. (Ministry of Public Health). www.msp.gob.uy Decree Nº 12/007 Regulates the quality and control of medicines for health care. Interchangeability of Products MSP perform inspections and certifies BA labs There is only one BA lab certified Private area 16

Av. Andrade Neves, 295 - Sala 184 - Ed. Torre São Paulo - Centro - Campinas/SP CEP: 13013-160 - F:(+55-19)3231 8146 secretaria@acbio.org.br - www.acbio.org.br Perspectives on bioanalysis in LATAM countries 17

Perspective Regulatory agencies are in general open for harmonization ANVISA is becoming an important player and might lead this process influencing other regional agencies (ANMAT, ISP, etc.) Definitely Brazil is in a step forward when compared to the rest of LATAM countries in terms of number of assays conducted technology already implemented size of the market Issues that would be more thoroughly discussed QA processes How to report data (documentation) GBC and other harmonization initiatives can help LATAM countries to better set up their guidelines and to move forward in a more rational way 18

Acknowlegments To the organizing committee of 3rd Open Forum - EBF To all the ACBio members To the contacts in each country which have given me all the information on the local perspective: Chile: Dr. Iván Saavedra and Dra. María Nella Gai México: QFB Oscar Alderete, Dr. Gabriel Marcelín Jimenez and QFB José Manuel Cárdenas Argentina: Dr. Mario Dominguez and Dr. Miguel Vago Uruguay: BSc. Mónica Cedrés Perú: M.Sc. Ofelia Villalva For contacting me: Rafael Barrientos - Bioanalytical Manager Email: Rafael.barrientos@magabi.com.br Tel./Fax: +55-11-5521 0232 Address: Av. das Nações Unidas, 22.215 São Paulo/SP - 04795-100 19

V Workshop on BE studies June 5-8th, 2011 Novotel Center Norte - São Paulo/SP For more information, visit our web site: www.acbio.org.br 20